Ching-WeiDavidTzengMDFACS
General Surgery • Houston, TXHepatobiliary Surgery, Pancreas
Associate Professor
Dr. Tzeng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161Fax+1 713-745-1921
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, HPB Surgery, 2012 - 2013- University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2010 - 2012
University of Alabama Medical CenterResidency, Surgery, 2003 - 2010
University of Alabama School of MedicineClass of 2003
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
GA State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
TX State Medical License 2010 - 2026
WA State Medical License 2023 - 2026
LA State Medical License 2023 - 2025- American Board of Surgery Surgery
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery Start of enrollment: 2019 Feb 28
- Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases Start of enrollment: 2022 Nov 16
Roles: Principal Investigator, Contact
- 5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial Start of enrollment: 2024 Mar 27
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Propensity Score-Matched Analysis of Liver Venous Deprivation and Portal Vein Embolization Before Planned Hepatectomy in Patients with Extensive Colorectal Liver Metas...Antony Haddad, Mohammad Mahdi Khavandi, Mateo Lendoire, Belkacem Acidi, Yi-Ju Chiang
Annals of Surgical Oncology. 2024-12-04 - Total Venous Control and Vein-to-the-Right Superior Mesenteric Artery Approach in Robotic Pancreatoduodenectomy.Madeline B Torres, Jessica E Maxwell, Rebecca A Snyder, Hop S Tran Cao, Michael P Kim
Annals of Surgical Oncology. 2024-12-01 - CEA Rebound After Discontinuation of Pre-Hepatectomy Chemotherapy Predicts Worse Outcomes After Resection of Colorectal Cancer Liver Metastases.Antony Haddad, Mateo Lendoire, Abhineet Uppal, Harufumi Maki, Ian Folkert
Annals of Surgical Oncology. 2024-11-08
Journal Articles
- Assessing the 5×-Multiplier Calculation to Reduce Discharge Opioid Prescription Volumes After Inpatient SurgeryRyan W Day, Timothy E Newhook, Ching-Wei D Tzeng, JAMA Surgery
- Response and Survival Associated with First-Line FOLFIRINOX vs Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal AdenocarcinomaShubham Pant, Milind Javle, Naruhiko Ikoma, Ching-Wei Tzeng, Jeffrey E Lee, JAMA Surgery
Authored Content
- Response and Survival Associated with First-Line FOLFIRINOX vs Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal AdenocarcinomaJuly 2020
- Response and Survival Associated with First-Line FOLFIRINOX vs Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal AdenocarcinomaJuly 2020
Press Mentions
Opioid-Free Discharge Feasible After PancreatectomySeptember 9th, 2023- Liver Regeneration: How the Liver’s Ability to Recover Plays into Liver Cancer SurgeryNovember 2nd, 2023
Professional Memberships
- Member
External Links
- Faculty Websitehttp://faculty.mdanderson.org/Ching-Wei_Tzeng/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
